Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 28, No. 1, 2009
Issue release date: August 2009
Section title: Original Research Article
Free Access
Dement Geriatr Cogn Disord 2009;28:75–80

Midlife Serum Cholesterol and Increased Risk of Alzheimer’s and Vascular Dementia Three Decades Later

Solomon A.a, b · Kivipelto M.a, b · Wolozin B.c · Zhou J.d · Whitmer R.A.d
aDepartment of Neurology, University of Kuopio, Kuopio, Finland; bAging Research Center, Karolinska Institutet, Stockholm, Sweden; cDepartment of Pharmacology, Boston University School of Medicine, Boston, Mass., and dDivision of Research, Kaiser Permanente, Oakland, Calif., USA
email Corresponding Author

Alina Solomon

Department of Neurology, University of Kuopio

PO Box 1627

FI–70211 Kuopio (Finland)

Tel. +46 8 690 5822, Fax +46 8 690 5954, E-Mail alina.solomon@uku.fi


  1. Kivipelto M, Solomon A: Cholesterol as a risk factor for Alzheimer’s disease – epidemiological evidence. Acta Neurol Scand Suppl 2006;185:50–57.
  2. Notkola IL, Sulkava R, Pekkanen J, et al: Serum total cholesterol, apolipoprotein E ε4 allele, and Alzheimer’s disease. Neuroepidemiology 1998;17:14–20.
  3. Kivipelto M, Helkala EL, Laakso MP, et al: Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med 2002;137:149–155.
  4. Kalmijn S, Foley D, White L, et al: Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men: the Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol 2000;20:2255–2260.
  5. Tan ZS, Seshadri S, Beiser A, et al: Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Arch Intern Med 2003;163:1053–1057.
  6. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K: Midlife cardiovascular risk factors and risk of dementia in late-life. Neurology 2005;64:277–281.
  7. Krieger N: Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 1992;82:703–710.
  8. Collen MF: Multiphasic Health Testing Services. New York, John Wiley & Sons, 1978.
  9. Collen MF, Davis LF: The multitest laboratory in health care. J Occup Med 1969;11:355–360.
  10. Iribarren C, Sidney S, Sternfeld B, Browner WS: Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease. JAMA 2000;283:2810–2815.
  11. Arellano MG, Petersen GR, Petitti DB, Smith RE: The California Automated Mortality Linkage System (CAMLIS). Am J Public Health 1984;74:1324–1330.
  12. National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Final Report (NIH Publication No. 02-5215). Bethesda, National Heart, Lung and Blood Institute, National Institutes of Health, 2002.
  13. Solomon A, Kåreholt I, Ngandu T, et al: Serum cholesterol changes after midlife and late-life cognition: 21-year follow-up study. Neurology 2007;68:751–756.
  14. Stewart R, White LR, Xue QL, Launer LJ: Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol 2007;64:103–107.
  15. Bjorkhem I: Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med 2006;260:493–508.
  16. Hachinski V, Iadecola C, Petersen RC, et al: National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006;37:2220–2241.
  17. Romero JR: Prevention of ischemic stroke: overview of traditional risk factors. Curr Drug Targets 2007;8:794–801.
  18. He K, Xu Y, van Horn L: The puzzle of dietary fat intake and risk of ischemic stroke: a brief review of epidemiologic data. J Am Diet Assoc 2007;107:287–295.
  19. Rockwood K: Epidemiological and clinical trials evidence about a preventive role for statins in Alzheimer’s disease. Acta Neurol Scand Suppl 2006;185:71–77.
  20. Aguero-Torres H, Kivipelto M, von Strauss E: Rethinking the dementia diagnoses in a population-based study: what is Alzheimer’s disease and what is vascular dementia? A study from the Kungsholmen project. Dement Geriatr Cogn Disord 2006;22:244–249.
  21. Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J: Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol 2006;5:735–741.
  22. Hachinski V: Stroke and vascular cognitive impairment: a transdisciplinary, translational and transactional approach. Stroke 2007;38:1396–1403.